L-Glutaminyl-L-threonine | 74408-69-8

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: L-Glutaminyl-L-threonine
• 英文别名: (2S,3R)-2-[[(2S)-2,5-diamino-5-oxopentanoyl]amino]-3-hydroxybutanoic acid
• CAS: 74408-69-8
• 化学式: C₉H₁₇N₃O₅
• 分子量: 247.25
• InChiKey: HHSJMSCOLJVTCX-ZDLURKLDSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -5
• 重原子数：
  17
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  156
• 氢给体数：
  5
• 氢受体数：
  6

文献信息

• Compositions to improve tic disorders
  申请人：Ozeki Makoto

  公开号：US20060217321A1

  公开（公告）日：2006-09-28

  Tic disorders can be improved by administering theanine, an amino acid that crosses the blood-brain barrier, or a dipeptide consisting of theanine and a different amino acid. In addition, these compositions can be added to foods and drinks or pharmaceuticals.

  滴状障碍可以通过给予茶氨酸改善，这是一种可以穿过血脑屏障的氨基酸，或者是由茶氨酸和另一种氨基酸组成的二肽。此外，这些组合物可以添加到食品和饮料或药品中。
• Method for obtaining peptide fragments by use of fluorinated organic acids
  申请人：SEIKO INSTRUMENTS INC.

  公开号：EP0885899A1

  公开（公告）日：1998-12-23

  This method obtains peptide fragments having ends of specific amino acids from a protein, which does not use an enzyme and thus is associated with minimum contamination. An organic acid represented by a general formula; CF3-(CF2) n-COOH, wherein n is an integer of 0 or larger, is allowed to act on a protein or peptide.

  这种方法可以从蛋白质中获得具有特定氨基酸末端的肽片段，无需使用酶，因此污染最小。通式为 CF3-(CF2) n-COOH（其中 n 为 0 或更大的整数）的有机酸可作用于蛋白质或肽。
• Biomarkers for cardiovascular diseases and methods using the same
  申请人：Metabolon, Inc.

  公开号：US10175233B2

  公开（公告）日：2019-01-08

  Biomarkers relating to cardiovascular disease, including atherosclerosis and cardiomyopathy, are provided, as well as methods for using such biomarkers as biomarkers for cardiovascular disease. In addition, methods for modulating the respective disorders or conditions of a subject are also provided. Also provided are suites of small molecule entities as biomarkers for cardiovascular disease, including atherosclerosis and cardiomyopathy.

  本研究提供了与心血管疾病（包括动脉粥样硬化和心肌病）有关的生物标志物，以及将此类生物标志物用作心血管疾病生物标志物的方法。此外，还提供了调节受试者相应疾病或状况的方法。还提供了作为心血管疾病（包括动脉粥样硬化和心肌病）生物标志物的成套小分子实体。
• IMPROVED PROCESS FOR THE PRODUCTION OF SEMI-SYNTHETIC CEPHALOSPORINS VIA EXPANDASE ACTIVITY ON PENICILLIN G
  申请人：GIST-BROCADES B.V.

  公开号：EP0863989A2

  公开（公告）日：1998-09-16
• METHODS AND USES FOR METABOLIC PROFILING FOR CLOSTRIDIUM DIFFICILE INFECTION
  申请人：The Board of Regents of The University of Texas System

  公开号：EP2776829A1

  公开（公告）日：2014-09-17